Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1161 results for "us food and drug administration"

Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review
Nasdaq

US FDA accepts for review OPKO's NDA for Rayaldee

The US Food and Drug Administration (FDA) has accepted for review OPKO's New Drug Application (NDA) for calcifediol modified-release capsules (proposed trade name, Rayaldee). In the NDA, OPKO seeks approval of Rayaldee for the prevention and ... PharmaBiz, 16 hours ago
[x]  

1,705 images for us food and drug administration

Just-Food, 4 days ago
Sky News Australia, 6 days ago
Farm Futures, 1 day ago
Eurofresh Distribution, 1 week ago
Daily Caller, 3 weeks ago
Toronto Star Online, 6 days ago
Pharmaceutical Journal, 3 days ago
Pharmaceutical Journal, 4 days ago
Pharmaceutical Journal, 2 weeks ago
MeatPoultry.com, 1 week ago
Livemint.com

Strides Arcolab receives ANDA approval from US FDA for benzonatate softgel capsules

Strides Arcolab has received approval from the United States Food & Drug Administration (FDA) for benzonatate capsules USP, 100 mg and 200 mg. According to IMS data, the US market for benzonatate is approximately US$ 41 million. The product will ...
 PharmaBiz12 hours ago Strides Arcolab gets US FDA nod for cough drug  Hindu Business Line13 hours ago Strides Arcolab gets USFDA nod for Benzonatate capsules  The Financial Chronicle16 hours ago Adapt Pharma seeks US FDA nod for Narcan nasal spray to treat opioid overdose  PharmaBiz1 day ago
[x]  
Pharma Letter

U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Nave Metastatic Castration-Resistant Prostate Cancer.

The U.S. Food and Drug Administration approved enzalutamide for the treatment of patients with chemotherapy-nave metastatic castration-resistant prostate cancer (mCRPC). At the prespecified interim analysis, a statistically significant improvement ...
 UroToday7 hours ago FDA approves new drug for treatment of type 2 diabetes  Pakistan Observer1 day ago AbbVie gets FDA nod for combination HCV drug  Pharma Letter4 days ago AbbVie, Bristol-Myers get FDA nod for hep C treatments  Reuters1 week ago
[x]  
CBS News

CBS Health: FDA warns: Don't get these two drugs mixed up

The Food and Drug Administration said Thursday that some doctors and pharmacies are getting confused by the similar names of an antidepressant and a blood-thinning medicine. The FDA says it's not aware of any patients who took the wrong drug, but ...
 CBS News8 hours ago This Is How Easy It Is to Pick Up the Wrong Prescription Drug  Bloomberg1 day ago Brilinta? Brintellix? FDA warns of drug name mix-ups  SiliconValley.com1 day ago
[x]  
Med India

US FDA Approves New Non Surgical Balloon System for Effective Weight Loss

The U.S. Food and Drug Administration has approved the ReShape Integrated Dual Balloon System, the first-of-its-kind non-surgical weight loss procedure for people who either do not want or do not qualify for bariatric surgery. The system was ...
 MedIndia11 hours ago

Neos resubmits ADHD drug application for FDA review

Neos Therapeutics has resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its amphetamine XR orally disintegrating tablet (XR-ODT) product candidate, NT‐0202, to treat attention deficit hyperactivity disorder ...
 Pharmaceutical Business Review13 hours ago Neos Therapeutics Resubmits New Drug Application for FDA Review of Amphetamine Extended-Release Orally Disintegrating Tablets to Treat ADHD  Business Wire1 day ago Neos Therapeutics resubmits NDA to the US FDA for ADHD product candidate NT-0202  Individual.com15 hours ago Neos Therapeutics : Resubmits New Drug Application for FDA Review of Amphetamine Extended-Release Orally Disintegrating Tablets to Treat ADHD  4 Traders1 day ago
[x]  
TheStreet.com

US FDA accepts for review Merck's NDA for grazoprevir/elbasvir to treat chronic hepatitis C

The US Food and Drug Administration (FDA) has accepted for review Merck's New Drug Application for grazoprevir/elbasvir (100mg/50mg), an investigational, once-daily, single-tablet combination therapy for the treatment of adult patients infected with ...
 PharmaBiz19 hours ago Merck Announces U.S. Food And Drug Administration Acceptance Of New Drug Application For Grazoprevir/Elbasvir, An Investigational Therapy For Treatment Of Chronic Hepatitis C Genotypes 1, 4 And 6 Infection  TheStreet.com3 days ago MERCK : Announces U.S. Food and Drug Administration Acceptance of New Drug Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Genotypes 1, 4 and 6 Infection  4 Traders3 days ago
[x]  
MedIndia

US FDA Approves Halo Closed System Transfer Device from Corvida Medical

The US Food and Drug Administration (FDA) has approved the Halo Closed System Transfer Device (CSTD) of the first product of the emerging medical device firm, Corvida Medical. Thousands of health care workers are exposed to hazardous drugs every ...
 MedIndia12 hours ago
India Infoline

Top Pharma news of the day

India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi said. (ET) India's largest drugmaker Sun Pharma may file application ...
 India Infoline18 hours ago Sun Pharma May File New Drug Application with USFDA: Shanghvi  New Indian Express1 day ago Sun Pharma to file new drug application with USFDA: Report  Indian-Commodity16 hours ago
[x]  
SPi World News

Finacea(R) (azelaic acid) Foam 15%, Approved by U.S. FDA for Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate Rosacea

(GLOBE NEWSWIRE) -- As announced today by Bayer HealthCare, the U.S. Food & Drug Administration (FDA) has approved Finacea® (azelaic acid) Foam, 15% for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.
 Financial Content12 hours ago Foamix Pharmaceuticals, Ltd. Release: Finacea (Azelaic Acid) Foam 15%, Approved By U.S. Foamix Pharmaceuticals, Ltd. For Topical Treatment Of The Inflammatory Papules And Pustules Of Mild To Moderate Rosacea  BioSpace9 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - us food and drug administration
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less